Tennessee Oncology - Nashville — Nashville, Tennessee

Tennessee Oncology - Nashville is a clinical research site located in Nashville, Tennessee, United States 37203.

Crixeo Health Trust Score: 81/100 (GOOD). This profile has not yet been claimed by the site owner.

Tennessee Oncology - Nashville has participated in 22 clinical trials with 7 currently active.

Therapeutic areas: Advanced Gastrointestinal Cancer, Diffuse Large B-Cell Lymphoma, Advanced Cancer.

Sponsors: Sumitomo Pharma America, Inc., Hoffmann-La Roche, Jazz Pharmaceuticals.

Sponsor Feasibility Report

Trust Score: 81/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Tennessee Oncology - Nashville?

Tennessee Oncology - Nashville has a Crixeo Trust Score of 81/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Tennessee Oncology - Nashville conducted?

Tennessee Oncology - Nashville has 22 clinical trials on record, with 7 currently active. Their work covers Advanced Gastrointestinal Cancer, Diffuse Large B-Cell Lymphoma, Advanced Cancer.

Is Tennessee Oncology - Nashville accredited by Crixeo Health?

Yes — Tennessee Oncology - Nashville holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about Tennessee Oncology - Nashville?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.